Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Aug;56(2):376–385. doi: 10.1172/JCI108102

Specificity of opsonic antibodies to enhance phagocytosis of Pseudomonas aeruginosa by human alveolar macrophages.

H Y Reynolds, J A Kazmierowski, H H Newball
PMCID: PMC436596  PMID: 807599

Abstract

These studies compared the ability of specific secretory IgA (sIgA) and IgG antibodies to promote phagocytosis of viable pseudomonas aeruginosa by human alveolar macrophages. Macrophages were obtained by lung lavage of normal adult smoker and nonsmoker volunteers and were maintained as in vitro cell monolayers. Both immune sIgA and IgG agglutinating antibodies were demonstrated to coat and opsonize viable bacteria, whereas similar nonimmune immunoglobulin preparations did not. When alveolar macrophages were challenged with viable opsonized 14C-labeled Pseudomonas IgG-reacted bacteria were ingested better and killed more readily than sIgA-opsonized organisms. Phagocytic responses were not significantly different between macrophages obtained from smokers and nonsmokers. Although sIgA and IgG antibodies can be found in respiratory secretions and both are undoubtedly important in pulmonary host defense, IgG opsonic antibody was superior in enhancing the uptake of Pseudomonas by in vitro-cultured alveolar macrophages. It may be the more important respiratory antibody for certain bacterial infections.

Full text

PDF
376

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. COHN Z. A., WIENER E. THE PARTICULATE HYDROLASES OF MACROPHAGES. II. BIOCHEMICAL AND MORPHOLOGICAL RESPONSE TO PARTICLE INGESTION. J Exp Med. 1963 Dec 1;118:1009–1020. doi: 10.1084/jem.118.6.1009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cantrell E. T., Warr G. A., Busbee D. L., Martin R. R. Induction of aryl hydrocarbon hydroxylase in human pulmonary alveolar macrophages by cigarette smoking. J Clin Invest. 1973 Aug;52(8):1881–1884. doi: 10.1172/JCI107371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen A. B., Cline M. J. The human alveolar macrophage: isolation, cultivation in vitro, and studies of morphologic and functional characteristics. J Clin Invest. 1971 Jul;50(7):1390–1398. doi: 10.1172/JCI106622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Crowder J. G., Fisher M. W., White A. Type-specific immunity in pseudomonas diseases. J Lab Clin Med. 1972 Jan;79(1):47–54. [PubMed] [Google Scholar]
  5. Eddie D. S., Schulkind M. L., Robbins J. B. The isolation and biologic activities of purified secretory IgA and IgG anti-Salmonella typhimurium "O" antibodies from rabbit intestinal fluid and colostrum. J Immunol. 1971 Jan;106(1):181–190. [PubMed] [Google Scholar]
  6. Falk G. A., Okinaka A. J., Siskind G. W. Immunoglobulins in the bronchial washings of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1972 Jan;105(1):14–21. doi: 10.1164/arrd.1972.105.1.14. [DOI] [PubMed] [Google Scholar]
  7. Fisher M. W., Devlin H. B., Gnabasik F. J. New immunotype schema for Pseudomonas aeruginosa based on protective antigens. J Bacteriol. 1969 May;98(2):835–836. doi: 10.1128/jb.98.2.835-836.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fudenberg H., Good R. A., Goodman H. C., Hitzig W., Kunkel H. G., Roitt I. M., Rosen F. S., Rowe D. S., Seligmann M., Soothill J. R. Primary immunodeficiencies. Report of a World Health Organization Committee. Pediatrics. 1971 May;47(5):927–946. [PubMed] [Google Scholar]
  9. Golde D. W., Finley T. N., Cline M. J. The pulmonary macrophage in acute leukemia. N Engl J Med. 1974 Apr 18;290(16):875–878. doi: 10.1056/NEJM197404182901603. [DOI] [PubMed] [Google Scholar]
  10. Graybill J. R., Marshall L. W., Charache P., Wallace C. K., Melvin V. B. Nosocomial pneumonia. A continuing major problem. Am Rev Respir Dis. 1973 Nov;108(5):1130–1140. doi: 10.1164/arrd.1973.108.5.1130. [DOI] [PubMed] [Google Scholar]
  11. Green G. M. Alveolobronchiolar transport mechanisms. Arch Intern Med. 1973 Jan;131(1):109–114. [PubMed] [Google Scholar]
  12. Green G. M. The J. Burns Amberson Lecture--in defense of the lung. Am Rev Respir Dis. 1970 Nov;102(5):691–703. doi: 10.1164/arrd.1970.102.5.691. [DOI] [PubMed] [Google Scholar]
  13. HANKS J. H., WALLACE J. H. Determination of cell viability. Proc Soc Exp Biol Med. 1958 May;98(1):188–192. doi: 10.3181/00379727-98-23985. [DOI] [PubMed] [Google Scholar]
  14. Harris J. O., Swenson E. W., Johnson J. E., 3rd Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers. J Clin Invest. 1970 Nov;49(11):2086–2096. doi: 10.1172/JCI106426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Heiner D. C., Evans L. Immunoglobulins and other proteins in commercial preparations of gamma globulin. J Pediatr. 1967 May;70(5):820–827. doi: 10.1016/s0022-3476(67)80341-x. [DOI] [PubMed] [Google Scholar]
  16. KEIMOWITZ R. I. IMMUNOGLOBULINS IN NORMAL HUMAN TRACHEOBRONCHIAL WASHINGS: A QUALITATIVE AND QUANTITATIVE STUDY. J Lab Clin Med. 1964 Jan;63:54–59. [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. Martin R. R. Altered morphology and increased acid hydrolase content of pulmonary macrophages from cigarette smokers. Am Rev Respir Dis. 1973 Apr;107(4):596–601. doi: 10.1164/arrd.1973.107.4.596. [DOI] [PubMed] [Google Scholar]
  19. Martinez-Tello F. J., Braun D. G., Blanc W. A. Immunoglobulin production in bronchial mucosa and bronchial lymph nodes, particularly in cystic fibrosis of the pancreas. J Immunol. 1968 Nov;101(5):989–1003. [PubMed] [Google Scholar]
  20. Newcomb R. W., Normansell D., Stanworth D. R. A structural study of human exocrine IgA globulin. J Immunol. 1968 Nov;101(5):905–914. [PubMed] [Google Scholar]
  21. Pennington J. E., Reynolds H. Y., Carbone P. P. Pseudomonas pneumonia. A retrospective study of 36 cases. Am J Med. 1973 Aug;55(2):155–160. doi: 10.1016/0002-9343(73)90163-0. [DOI] [PubMed] [Google Scholar]
  22. Pratt S. A., Smith M. H., Ladman A. J., Finley T. N. The ultrastructure of alveolar macrophages from human cigarette smokers and nonsmokers. Lab Invest. 1971 May;24(5):331–338. [PubMed] [Google Scholar]
  23. Rabinovitch M., De Stefano M. J. Particle recognition by cultivated macrophages. J Immunol. 1973 Mar;110(3):695–701. [PubMed] [Google Scholar]
  24. Reynolds H. Y., Atkinson J. P., Newball H. H., Frank M. M. Receptors for immunoglobulin and complement on human alveolar macrophages. J Immunol. 1975 Jun;114(6):1813–1819. [PubMed] [Google Scholar]
  25. Reynolds H. Y., Johnson J. S. Structural units of canine serum and secretory immunoglobulin A. Biochemistry. 1971 Jul 20;10(15):2821–2827. doi: 10.1021/bi00791a003. [DOI] [PubMed] [Google Scholar]
  26. Reynolds H. Y., Newball H. H. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage. J Lab Clin Med. 1974 Oct;84(4):559–573. [PubMed] [Google Scholar]
  27. Reynolds H. Y., Thompson R. E., Devlin H. B. Development of cellular and humoral immunity in the respiratory tract of rabbits to Pseudomonas lipopolysaccharide. J Clin Invest. 1974 May;53(5):1351–1358. doi: 10.1172/JCI107683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Reynolds H. Y., Thompson R. E. Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa. J Immunol. 1973 Aug;111(2):358–368. [PubMed] [Google Scholar]
  29. Reynolds H. Y., Thompson R. E. Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages. J Immunol. 1973 Aug;111(2):369–380. [PubMed] [Google Scholar]
  30. Reynolds H., Carta-Sorcini M., Mage R. The immunoglobulins derived from a VH-CH recombinant rabbit and its normal relatives. I. Measurements of heavy chain molecular weights and allotypes of colostral IgA. Immunochemistry. 1973 Jul;10(7):443–447. doi: 10.1016/0019-2791(73)90014-1. [DOI] [PubMed] [Google Scholar]
  31. Rose H. D., Heckman M. G., Unger J. D. Pseudomonas aeruginosa pneumonia in adults. Am Rev Respir Dis. 1973 Mar;107(3):416–422. doi: 10.1164/arrd.1973.107.3.416. [DOI] [PubMed] [Google Scholar]
  32. Ross G. D., Polley M. J., Rabellino E. M., Grey H. M. Two different complement receptors on human lymphocytes. One specific for C3b and one specific for C3b inactivator-cleaved C3b. J Exp Med. 1973 Oct 1;138(4):798–811. doi: 10.1084/jem.138.4.798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tillotson J. R., Lerner A. M. Characteristics of nonbacteremic Pseudomonas pneumonia. Ann Intern Med. 1968 Feb;68(2):295–307. doi: 10.7326/0003-4819-68-2-295. [DOI] [PubMed] [Google Scholar]
  34. Tourville D. R., Adler R. H., Bienenstock J., Tomasi T. B., Jr The human secretory immunoglobulin system: immunohistoligical localization of gamma A, secretory "piece," and lactoferrin in normal human tissues. J Exp Med. 1969 Feb 1;129(2):411–429. doi: 10.1084/jem.129.2.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yeager H., Jr, Zimmet S. M., Schwartz S. L. Pinocytosis by human alveolar macrophages. Comparison of smokers and nonsmokers. J Clin Invest. 1974 Aug;54(2):247–251. doi: 10.1172/JCI107759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zipursky A., Brown E. J., Bienenstock J. Lack of opsonization potential of 11S human secretory A. Proc Soc Exp Biol Med. 1973 Jan;142(1):181–184. doi: 10.3181/00379727-142-36983. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES